Author:
Wyrwich Kathleen W.,Metz Stacie M.,Kroenke Kurt,Tierney William M.,Babu Ajit N.,Wolinsky Fredric D.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Food and Drug Administration. Innovation or Stagnation: Challenges And Opportunities on the Critical Path to New Medical Products. Washington, DC: US Department of Health and Human Services; March 2004.
2. Schunemann H, Guyatt GH. Commentary—goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res. 2005;40(2):593.
3. Jaeschke R, Singer J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–15.
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.com ; October 26, 2001.
5. Guyatt G, Berman L, Townsend M, Pugsley S, Chambers L. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–8.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献